Detalhe da pesquisa
1.
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
Neuro Oncol
; 25(2): 365-374, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868630
2.
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration.
Clin Pharmacol Ther
; 110(1): 210-219, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547646
3.
Response to "Intrathecal trastuzumab: What else do we need to consider?" by Gao et al.
Neuro Oncol
; 25(2): 420-421, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534958
4.
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.
Leuk Lymphoma
; 59(7): 1659-1665, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29179634